1/02/2025.
Melanoma is one of the most aggressive forms of skin cancer, responsible for 60% of lethal skin neoplasms. Early detection is crucial for improving patient outcomes, particularly as the incidence of melanoma continues to rise, posing an increasing public health challenge due to the aging population and extended life expectancy.
30/01/2025.
iToBoS partners held a joint workshop with the NEMECYS project to share information about project results (specifically the AI Privacy Risk Assessment tool) and gather feedback from relevant stakeholders from the health domain.
30/01/2025.
The fair is world’s premier event for lasers, biomedical optics, biophotonic technologies, quantum, vision technologies, and optoelectronics.
28/01/2025.
The start, preparation and validation of the data acquisition will be commanded by the HMI, the Hospital Operator Interface. This interface is crucial as it serves as the primary point of control and interaction for medical professionals during the scanning process.
25/01/2025.
Dr. Josep Malvehy was a speaker at the 28th Annual Meeting of the European Dermatology Forum (EDF), held in Montreux, Switzerland, from January 23 to 25, 2025.
24/01/2025.
Skin cancer is one of the most prevalent forms of cancer globally, reaching epidemic proportions.
21/01/2025.
The emergence of AI-generated art within therapeutic settings necessitates the establishment of guidelines to address ethical and privacy concerns including informed consent, data protection, and the confidentiality of patients’ medical images and resultant artworks.
17/01/2025.
The goal of this competition is to develop state-of-the-art machine learning techniques for detecting multiple skin lesions in clinical images.
15/01/2025.
The design of the iToBoS scanner places a strong emphasis on patient protection, particularly in the context of its robotic components operating in close proximity to the patient.
9/01/2025.
The COVID-19 pandemic accelerated the adoption of digital technologies in many areas of medicine.